Donate Toggle Menu
brad leibovich
Dr. Bradley C. Leibovich, Mayo Clinic

The Kidney Cancer Association (KCA) is pleased to announce Dr. Bradley C. Leibovich as Chairman of its Board of Directors.

Leibovich is a medical oncologist at the Mayo Clinic in Rochester, Minnesota and the David C. Utz, M.D., Professor of Urology at the Mayo Clinic College of Medicine. He was previously Chair of the KCA’s Medical Steering Committee (MSC), which provides strategic guidance for professional and community medical education activities, and served on the KCA board as the MSC representative.

Leibovich accepted the Chair position in November 2021 following a unanimous vote by the KCA’s Board of Directors during the November board meeting. He succeeds Dr. Christopher G. Wood, a urologic surgeon at the MD Anderson Cancer Center in Houston, Texas who chaired the board from 2016 until his death in November 2021.

“Having worked with Brad for many years and witnessed firsthand his dedication to the kidney cancer community, I have no doubt he will step into this new role seamlessly,” said Gretchen, E. Vaughan, President & CEO of the KCA. “We will always miss our dear friend Chris and remain grateful for the indelible mark his leadership left on the KCA. With Chris’s energetic and caring spirit at our backs, we are more determined than ever to reach new heights and work together to unlock the cure for kidney cancer. I’m grateful and honored that Brad will pick up that torch.”

As board Chair, Leibovich will work closely with all members of the KCA’s board and advisory councils (MSC, Clinical Advisory Board, and Patient & Caregiver Advisory Council) together with Vaughan to ensure the organization is advancing towards achieving its mission to serve those impacted by kidney cancer and lead change through advocacy, research, and education.

“The KCA is firmly on the path to change life for the better for people impacted by kidney cancer and I’ve been lucky to help along the way thus far,” Leibovich said. “Chris and I were good friends and though I continue to process the loss, it is my honor to be entrusted with this role and to work alongside some of the most talented, thoughtful people to innovate and set new standards in serving those with kidney cancer.”

Leibovich brings extensive clinical, research, and leadership experience to his role as Chair of the KCA’s Board of Directors. He most recently served as Chair of the Department of Urology at the Mayo Clinic. Leibovich has supported the wider kidney cancer community through the KCA for many years. During his time as a member of the board and leader of the MSC, Leibovich was involved in planning several of the KCA’s International Kidney Cancer Symposiums, leading the inaugural Think Tank: Coalition for a Cure meeting in 2019, and participating in the development of the KCA’s latest research initiative, the KCA Data Federation project.


About the Kidney Cancer Association

The Kidney Cancer Association is a global community dedicated to serving and empowering patients and caregivers, and leading change through advocacy, research, and education in order to be the universal leader in finding the cure for kidney cancer. Founded in 1990 by Eugene P. Schonfeld and a small group of patients and doctors in Chicago, Illinois, the KCA has grown into an international non-profit organization based in Houston, Texas. The KCA promotes scientific advances through two annual research symposiums and a robust grant program, participates in legislative advocacy, and seeks to be a source of education and resources for patients, caregivers, and anyone impacted by kidney cancer.

Media Contact

Radha Chitale
Director of Communications
847.332.1051 ext. 113 | [email protected]